Position in AZN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$188,968,844
+$8,561,455 QoQ
Shares Held
996,566
+8.9% QoQ
Ownership
0.064%
of shares outstanding
% of Portfolio
2.71%
of 13F equity value
Holder Rank
#99
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 92%
Shared 0%
None 8%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CAPITAL INTERNATIONAL SARL holds $469,974,787 across 11 Drug Manufacturers - General names. AZN ranks #1 (40.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
This page
|
996,566 | $188,968,844 | |
| 2 | LLY |
ELI LILLY & Co
|
153,860 | $184,544,315 | |
| 3 | ABBV |
AbbVie Inc.
|
113,870 | $28,654,246 | |
| 4 | AMGN |
Amgen Inc
|
74,744 | $27,066,297 | |
| 5 | PFE |
Pfizer Inc
|
785,251 | $18,908,844 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
94,347 | $5,436,274 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
40,168 | $5,074,825 | |
| 8 | GRFS |
Grifols SA
|
642,946 | $4,552,057 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $188,968,844 | 996,566 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $180,407,389 | 914,752 | Shares | Defined | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||